Implementing PFAS testing in the early development stages allows medical device manufacturers to prepare for potential regulatory updates
Accelerating hit-to-lead timelines, and strengthening end-to-end drug discovery and development services
Integrated facility to deliver end-to-end, customized workflows across life sciences, diagnostics, and applied markets
The capital raise will also support debt repayment or prepayment, improving the company's debt-to-equity ratio and overall financial resilience
Awards highlight Avantor's commitment to the Biopharma industry
The site’s GMP Certification has been successfully renewed
DurA Cycle is designed for large-scale commercial manufacturing of monoclonal antibodies,
Collaboration enables Brenntag to serve pharma customers in EMEA with chromatography silica gels
This patent-pending, high-efficiency chromatography media is used for the purification of novel peptide-based pharmaceuticals in the GLP-1 agonist class including type 2 diabetes and obesity treatments
New facility will strengthen the security of supply for global pharmaceutical and biotech customers and will support the continued development and production of lifesaving clinical and commercial-scale therapeutics for patients worldwide.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
